Perrigo (PRGO) Net Cash Flow (QoQ) (2013 - 2026)
Perrigo (PRGO) Net Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Perrigo | 1.98 Bn | 1.58 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 125.16% |
| Mar 28, 2026 | -277.51% |
| Dec 31, 2025 | 582.50% |
| Sep 27, 2025 | -210.50% |
| Jun 28, 2025 | 111.91% |
| Mar 29, 2025 | 82.70% |
| Dec 31, 2024 | -196.74% |
| Sep 28, 2024 | 899.47% |
| Jun 29, 2024 | -33.18% |
| Mar 30, 2024 | -160.37% |
| Dec 31, 2023 | 179.80% |
| Sep 30, 2023 | 50,600.00% |
| Jul 1, 2023 | 99.80% |
| Apr 1, 2023 | -143.36% |
| Dec 31, 2022 | 2,597.87% |
| Oct 1, 2022 | 99.67% |
| Jul 2, 2022 | -1,693.21% |
| Apr 2, 2022 | 143.79% |
| Dec 31, 2021 | -111.66% |
| Oct 2, 2021 | 1,312.81% |